CN111610325A - 肿瘤单细胞检测试剂盒 - Google Patents
肿瘤单细胞检测试剂盒 Download PDFInfo
- Publication number
- CN111610325A CN111610325A CN201910136753.8A CN201910136753A CN111610325A CN 111610325 A CN111610325 A CN 111610325A CN 201910136753 A CN201910136753 A CN 201910136753A CN 111610325 A CN111610325 A CN 111610325A
- Authority
- CN
- China
- Prior art keywords
- tumor
- sample loading
- single cell
- detection kit
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 73
- 238000001514 detection method Methods 0.000 title claims abstract description 48
- 210000004027 cell Anatomy 0.000 claims abstract description 114
- 238000011068 loading method Methods 0.000 claims abstract description 84
- 210000004881 tumor cell Anatomy 0.000 claims abstract description 74
- 239000011521 glass Substances 0.000 claims abstract description 38
- 238000010790 dilution Methods 0.000 claims abstract description 33
- 239000012895 dilution Substances 0.000 claims abstract description 33
- 150000002632 lipids Chemical class 0.000 claims abstract description 26
- 239000012192 staining solution Substances 0.000 claims abstract description 25
- 239000004005 microsphere Substances 0.000 claims abstract description 21
- 210000001124 body fluid Anatomy 0.000 claims abstract description 20
- 239000010839 body fluid Substances 0.000 claims abstract description 20
- 230000003075 superhydrophobic effect Effects 0.000 claims abstract description 14
- 238000010186 staining Methods 0.000 claims abstract description 7
- 239000000523 sample Substances 0.000 claims description 69
- 239000000243 solution Substances 0.000 claims description 25
- 239000007850 fluorescent dye Substances 0.000 claims description 11
- 238000007885 magnetic separation Methods 0.000 claims description 10
- 239000000975 dye Substances 0.000 claims description 5
- 239000002077 nanosphere Substances 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 239000002105 nanoparticle Substances 0.000 claims description 3
- 150000003904 phospholipids Chemical class 0.000 claims description 3
- 238000012163 sequencing technique Methods 0.000 abstract description 12
- 238000012268 genome sequencing Methods 0.000 abstract description 4
- 238000002474 experimental method Methods 0.000 description 17
- 238000000034 method Methods 0.000 description 13
- 101100115801 Streptomyces mobaraensis daip gene Proteins 0.000 description 9
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 9
- 238000005406 washing Methods 0.000 description 9
- 230000003321 amplification Effects 0.000 description 8
- 238000003199 nucleic acid amplification method Methods 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 7
- 201000011510 cancer Diseases 0.000 description 6
- 230000005284 excitation Effects 0.000 description 6
- 230000000007 visual effect Effects 0.000 description 6
- 238000010276 construction Methods 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 238000007622 bioinformatic analysis Methods 0.000 description 4
- 239000013592 cell lysate Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 238000005070 sampling Methods 0.000 description 4
- 238000012070 whole genome sequencing analysis Methods 0.000 description 4
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 3
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 3
- 102000013127 Vimentin Human genes 0.000 description 3
- 108010065472 Vimentin Proteins 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 210000005048 vimentin Anatomy 0.000 description 3
- SNKAWJBJQDLSFF-NVKMUCNASA-N 1,2-dioleoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC SNKAWJBJQDLSFF-NVKMUCNASA-N 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 2
- 102000018651 Epithelial Cell Adhesion Molecule Human genes 0.000 description 2
- 108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 description 2
- 102000053171 Glial Fibrillary Acidic Human genes 0.000 description 2
- 101710193519 Glial fibrillary acidic protein Proteins 0.000 description 2
- 206010048612 Hydrothorax Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 210000005046 glial fibrillary acidic protein Anatomy 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
- YPGZWUVVEWKKDQ-UHFFFAOYSA-M 4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide Chemical compound [I-].C1=CC(N(CCCCCCCCCCCCCCCC)CCCCCCCCCCCCCCCC)=CC=C1C=CC1=CC=[N+](C)C=C1 YPGZWUVVEWKKDQ-UHFFFAOYSA-M 0.000 description 1
- 102000000412 Annexin Human genes 0.000 description 1
- 108050008874 Annexin Proteins 0.000 description 1
- 101500016899 Arabidopsis thaliana C-terminally encoded peptide 8 Proteins 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 102000001301 EGF receptor Human genes 0.000 description 1
- 108060006698 EGF receptor Proteins 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 102100034256 Mucin-1 Human genes 0.000 description 1
- 108010008707 Mucin-1 Proteins 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 208000002151 Pleural effusion Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 230000002601 intratumoral effect Effects 0.000 description 1
- 238000000370 laser capture micro-dissection Methods 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000001531 micro-dissection Methods 0.000 description 1
- 208000027831 neuroepithelial neoplasm Diseases 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- TUFFYSFVSYUHPA-UHFFFAOYSA-M rhodamine 123 Chemical compound [Cl-].COC(=O)C1=CC=CC=C1C1=C(C=CC(N)=C2)C2=[O+]C2=C1C=CC(N)=C2 TUFFYSFVSYUHPA-UHFFFAOYSA-M 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000588 tumorigenic Toxicity 0.000 description 1
- 230000000381 tumorigenic effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54346—Nanoparticles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Nanotechnology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910136753.8A CN111610325A (zh) | 2019-02-25 | 2019-02-25 | 肿瘤单细胞检测试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910136753.8A CN111610325A (zh) | 2019-02-25 | 2019-02-25 | 肿瘤单细胞检测试剂盒 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111610325A true CN111610325A (zh) | 2020-09-01 |
Family
ID=72195642
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910136753.8A Pending CN111610325A (zh) | 2019-02-25 | 2019-02-25 | 肿瘤单细胞检测试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111610325A (zh) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN202322856U (zh) * | 2011-11-14 | 2012-07-11 | 江苏百奥特医疗仪器科技有限公司 | 用于高通量、高分辨免疫荧光染色的细胞培养装置 |
CN202322857U (zh) * | 2011-12-01 | 2012-07-11 | 刘小龙 | 用于高通量、高分辨成像的细胞培养印玻片 |
CN102680679A (zh) * | 2011-03-15 | 2012-09-19 | 中国科学院上海生命科学研究院 | 检测单细胞特异性抗体分泌的细胞微孔芯片及其制备方法 |
CN106498040A (zh) * | 2016-10-12 | 2017-03-15 | 浙江大学 | 一种分子标记微珠及基于该分子标记微珠的高通量单细胞测序方法 |
CN108031442A (zh) * | 2017-12-29 | 2018-05-15 | 猎源(上海)生物医药科技有限公司 | 一种纳米脂质磁球及其制备方法、分离提取游离dna的试剂盒及其应用 |
CN108535145A (zh) * | 2018-03-09 | 2018-09-14 | 深圳市瑞图生物技术有限公司 | 快速检测外周血液中网织红细胞数量的方法及装置 |
CN109266653A (zh) * | 2018-10-10 | 2019-01-25 | 中国科学院化学研究所 | 一种耐药异质性循环肿瘤细胞捕获与基因分析的试剂、装置和方法 |
-
2019
- 2019-02-25 CN CN201910136753.8A patent/CN111610325A/zh active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102680679A (zh) * | 2011-03-15 | 2012-09-19 | 中国科学院上海生命科学研究院 | 检测单细胞特异性抗体分泌的细胞微孔芯片及其制备方法 |
CN202322856U (zh) * | 2011-11-14 | 2012-07-11 | 江苏百奥特医疗仪器科技有限公司 | 用于高通量、高分辨免疫荧光染色的细胞培养装置 |
CN202322857U (zh) * | 2011-12-01 | 2012-07-11 | 刘小龙 | 用于高通量、高分辨成像的细胞培养印玻片 |
CN106498040A (zh) * | 2016-10-12 | 2017-03-15 | 浙江大学 | 一种分子标记微珠及基于该分子标记微珠的高通量单细胞测序方法 |
CN108031442A (zh) * | 2017-12-29 | 2018-05-15 | 猎源(上海)生物医药科技有限公司 | 一种纳米脂质磁球及其制备方法、分离提取游离dna的试剂盒及其应用 |
CN108535145A (zh) * | 2018-03-09 | 2018-09-14 | 深圳市瑞图生物技术有限公司 | 快速检测外周血液中网织红细胞数量的方法及装置 |
CN109266653A (zh) * | 2018-10-10 | 2019-01-25 | 中国科学院化学研究所 | 一种耐药异质性循环肿瘤细胞捕获与基因分析的试剂、装置和方法 |
Non-Patent Citations (4)
Title |
---|
曾子悦等: "循环肿瘤细胞在肿瘤治疗中的研究进展", 《生命的化学》 * |
李祖茂等: "波形蛋白真核表达质粒载体的构建及其在HepG2细胞中的表达", 《川北医学院学报》 * |
贾永喜等: "人波形蛋白重组质粒表达降低乳腺癌的增殖和侵袭", 《西部医学》 * |
辛林等: "叶酸-壳聚糖Prdx6 shRNA纳米粒的构建及其对胃癌细胞增殖的影响", 《中国生物工程杂志》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20240228921A1 (en) | Method and device for detecting circulating tumor cell | |
US20220390734A1 (en) | Method and system for imaging a blood sample | |
JP6965272B2 (ja) | 高スループット粒子捕捉および分析 | |
US8481336B2 (en) | Magnetic separation device for cell sorting and analysis | |
JP7125418B2 (ja) | 蛍光画像における標的分子密度決定 | |
US7666308B2 (en) | Magnetic separation apparatus and methods | |
US8569077B2 (en) | Imaging of immunomagnetically enriched rare cells | |
US20110212440A1 (en) | Cell sorting device | |
CN110339874B (zh) | 一种外泌体分离与表面蛋白检测微流控装置及使用方法 | |
US8110101B2 (en) | Method and apparatus for imaging target components in a biological sample using permanent magnets | |
US20120097610A1 (en) | Method and apparatus for microfiltration to perform cell separation | |
AU2016228165A1 (en) | Methods for obtaining single cells and applications of single cell omics | |
WO2005061075A1 (en) | Magnetic separation apparatus and methods | |
US20130122513A1 (en) | Detection of magnetically labeled biological components | |
CN107860912B (zh) | 一种双功能化核酸适体介导的a549肿瘤细胞检测方法 | |
US20160124206A1 (en) | Poc-test system with mobile computer unit and method | |
CN111610325A (zh) | 肿瘤单细胞检测试剂盒 | |
CN109270262B (zh) | 一种基于微流体技术的激光单细胞提取方法 | |
US20230221319A1 (en) | A Method, A System, An Article, A Kit And Use Thereof For Biomolecule, Bioorganelle, Bioparticle, Cell And Microorganism Detection | |
CN111596053B (zh) | Tpn分子在制备循环肿瘤细胞检测试剂中的用途及检测试剂和试剂盒 | |
JP7486823B2 (ja) | 粒子捕捉システムおよび方法 | |
Chícharo et al. | Evolution in Automatized Detection of Cells: Advances in Magnetic Microcytometers for Cancer Cells | |
CN112955260A (zh) | 生物样品保持器和处理器 | |
Li | Microfluidic Single-Cell Analysis from Phenotype to Genotype | |
JP4622478B2 (ja) | 微生物計測方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20240325 Address after: Floor 4, Building 1, South the Taihu Lake Elite Industrial Park, 800 Rujiadian Road, Lianshi Town, Nanxun District, Huzhou City, Zhejiang Province, 313000 (self declaration) Applicant after: Huzhou Congrui Biotechnology Co.,Ltd. Country or region after: China Address before: 313013 no.800, rujiadian Road, Lianshi Town, Nanxun District, Huzhou City, Zhejiang Province Applicant before: HUZHOU LIEYUAN MEDICAL LABORATORY CO.,LTD. Country or region before: China |